Stay updated with breaking news from Bend Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CoreRx, Inc. today announced that it has completed its acquisition of Societal CDMO, Inc. , a contract development and manufacturing organization dedicated to solving complex formulation and...
CLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- CoreRx, Inc. ("CoreRx") today announced that it has completed its acquisition of Societal CDMO, Inc. ("Societal CDMO") (NASDAQ:SCTL), a contract development and
CoreRx set to acquire Societal CDMO in a $1.10 per share cash deal. Gain insights into this strategic move for drug formulation and manufacturing. Transaction expected to close in Q2 2024.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through...
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to...